These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34956870)

  • 1. CD146 as a Prognostic-Related Biomarker in ccRCC Correlating With Immune Infiltrates.
    Lv Z; Feng HY; Tao W; Li HZ; Zhang X
    Front Oncol; 2021; 11():744107. PubMed ID: 34956870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLK4 Is a Potential Biomarker for Abnormal Tumor Proliferation, Immune Infiltration, and Prognosis in ccRCC.
    Hu C; Liu Q; Hu C; Wang Y; Wang P; Zhou X
    Comput Math Methods Med; 2022; 2022():6302234. PubMed ID: 36176741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High GTSE1 expression promotes cell proliferation, metastasis and cisplatin resistance in ccRCC and is associated with immune infiltrates and poor prognosis.
    Lei P; Zhang M; Li Y; Wang Z
    Front Genet; 2023; 14():996362. PubMed ID: 36999057
    [No Abstract]   [Full Text] [Related]  

  • 4. POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Tian J; Cheng C; Gao J; Fu G; Xu Z; Chen X; Wu Y; Jin B
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma.
    Peng H; Du X; Zhang Y
    Front Mol Biosci; 2022; 9():898567. PubMed ID: 35720121
    [No Abstract]   [Full Text] [Related]  

  • 6. PTPRO predicts patient prognosis and correlates with immune infiltrates in human clear cell renal cell carcinoma.
    Gan J; Zhang H
    Transl Cancer Res; 2020 Aug; 9(8):4800-4810. PubMed ID: 35117843
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Cheng X; Sun D; Li H; Zhang J; Luo Q; Jin X; Chen Y; Yuan Q; Wang B
    Transl Androl Urol; 2023 Apr; 12(4):642-658. PubMed ID: 37181237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma.
    Zhang Y; Hua X; Shi H; Zhang L; Xiao H; Liang C
    Cancer Cell Int; 2021 Dec; 21(1):680. PubMed ID: 34923969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
    Cui Y; Zhou Z; Chai Y; Zhang Y
    J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics screening of prognostic immune-related genes in renal clear cell carcinoma.
    Cui K; Song H; Zhang H; Sun P
    J Appl Genet; 2024 May; ():. PubMed ID: 38780866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma.
    Feng H; Wang T; Ye J; Yang Y; Huang X; Lai D; Lv Z; Huang Y; Zhang X
    Discov Oncol; 2022 Dec; 13(1):134. PubMed ID: 36477668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGFLR1 as a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer Correlating With Immune Infiltrates.
    Song W; Shao Y; He X; Gong P; Yang Y; Huang S; Zeng Y; Wei L; Zhang J
    Front Mol Biosci; 2020; 7():565173. PubMed ID: 33324675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive analysis of the prognostic value and immune infiltration of low expression DBT in clear cell renal cell carcinoma.
    Xie W; Xi P; Liu Y; Zhang Z; Sun T
    Front Pharmacol; 2022; 13():1002588. PubMed ID: 36299888
    [No Abstract]   [Full Text] [Related]  

  • 14. A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma.
    Meng W; Chen B; Jiang Z; Cai B; Ma L; Guan Y
    Transl Cancer Res; 2023 Aug; 12(8):2071-2098. PubMed ID: 37701098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of Clinical Predictive Value and Immune Characterization of SLFN11 in Clear Cell Renal Cell Carcinoma.
    Liu Y; Zhang Z; Fu S; Wang S; Cheng X; Lei K; Li Z; Sun T; Ma M
    Int J Gen Med; 2021; 14():6741-6754. PubMed ID: 34675634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identify AGAP2 as prognostic biomarker in clear cell renal cell carcinoma based on bioinformatics and IHC staining.
    Xu Z; Wang Y; Xu J; Ang X; Ge N; Xu M; Pei C
    Heliyon; 2023 Feb; 9(2):e13543. PubMed ID: 36846683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of MAX dimerization protein 3 (MXD3) predicts poor prognosis in clear cell renal cell carcinoma.
    Zhang F; Liu L; Wu P; Li S; Wei D
    Transl Androl Urol; 2021 Feb; 10(2):785-796. PubMed ID: 33718080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma.
    Guo H; Jiang S; Sun H; Shi B; Li Y; Zhou N; Zhang D; Guo H
    Dis Markers; 2022; 2022():9443407. PubMed ID: 35299868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Expression of CD39 is Associated with Poor Prognosis and Immune Infiltrates in Clear Cell Renal Cell Carcinoma.
    Wu J; Wang YC; Xu WH; Luo WJ; Wan FN; Zhang HL; Ye DW; Qu YY; Zhu YP
    Onco Targets Ther; 2020; 13():10453-10464. PubMed ID: 33116625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.